Friday, September 25, 2009

Meterra Capsules, Lisdexamfetamine, metera, taj pharma, lisdexamefetamine, capsules metarr, meaterra, taj pharmaceuticals, miterra, lisdexa capsules,


DRUG DESCRIPTION
Meterra is designed as a capsule for once-a-day oral administration.Meterra capsules contain 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg of lisdexamfetamine dimesylate and the following inactive ingredients: microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.

Special Diagnostic Considerations
Specific etiology of this syndrome is unknown, and there is no single diagnostic test. Adequate diagnosis requires the use not only of medical but also of special psychological, educational, and social resources. Learning may or may not be impaired. The diagnosis must be based upon a complete history and evaluation of the patient and not solely on the presence of the required number of DSM-IV characteristics.

Long-Term Use
The effectiveness of Meterra for long-term use, i.e., for more than 4 weeks, has not been systematically evaluated in controlled trials. Therefore, the physician who elects to use Meterra for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient.

Meterra should be taken in the morning. Afternoon doses should be avoided because of the potential for insomnia.

Meterra may be taken with or without food.

Meterra capsules may be taken whole, or the capsule may be opened and the entire contents dissolved in a glass of water. The solution should be consumed immediately and should not be stored. The dose of a single capsule should not be divided. The contents of the entire capsule should be taken, and patients should not take anything less than one capsule per day.

CONTRAINDICATIONS
  • Advanced arteriosclerosis, symptomatic cardiovascular disease, moderate to severe hypertension, hyperthyroidism, known hypersensitivity or idiosyncratic reaction to sympathomimetic amines, glaucoma
  • Agitated states
  • Patients with a history of drug abuse
  • During or within 14 days following the administration of monoamine oxidase inhibitors (hypertensive crises may result)

Meterra Blister of 10 Capsules